Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Controlled human infection models as a strategy to accelerate SARS-CoV-2 vaccine development

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

2 Jul 2020

Study provides possible explanations for silent hypoxemia in COVID-19 patients

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing).

2 Jul 2020

Newer form of SARS-CoV-2 coronavirus dominates global infections

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

2 Jul 2020

Study shows oropharyngeal secretions as alternative for COVID-19 detection

As the global battle to understand and eliminate the coronavirus continues, a new study published in the Journal of Dental Research demonstrates that testing of oropharyngeal secretions may reduce the number of false-negative results from nasal swab testing of patients who have seemingly recovered from the disease.

2 Jul 2020

New study supports a causal relation of SARS-CoV-2 with COVID toes

There's considerable controversy over whether "COVID toes"—red sores or lesions on the feet and hands in children and young adults—are truly caused by COVID-19.

2 Jul 2020

Coronavirus shares common characteristics with global heating and species extinction, argue researchers

The dynamics of the SARS-CoV-2 pandemic share "striking similarities" with the twin environmental crises of global heating and species extinction, argue a team of scientists and policy experts from the UK and US.

2 Jul 2020

Researchers investigate decision-making processes implemented by Swiss government during COVID-19 crisis

At the beginning of the coronavirus crisis, Switzerland declared a four-month-long state of emergency, the country's longest since the Second World War.

2 Jul 2020

Researchers identify mosquito species that could transmit malaria

During collections for a study to map the distribution of mosquito species in Finland, Anopheles daciae, a species previously not known to occur in Finland was found from several locations in the south of the country.

2 Jul 2020

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.

2 Jul 2020

Structure of the full SARS-CoV-2 RNA genome in infected cells

The current COVID-19 pandemic caused by a single-stranded RNA virus, thought to have jumped across species barriers to infect humans, has spread rapidly across the globe infecting over 10 million individuals. The virus, now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the causative agent of COVID-19 disease. COVID-19 disease is a respiratory illness where symptoms can range from very mild to severe and include fever, coughing, a sore throat, and shortness of breath.

2 Jul 2020

SARS-CoV-2 infection modeling in iPSC-derived type 2 cells

The most fatal form of COVID-19 disease is acute respiratory distress syndrome (ARDS), caused by direct viral injury as well as indirect noxious effects caused by cytotoxic chemicals and inflammatory processes. A new study published on the preprint server bioRxiv* in June 2020 shows that this is partly due to the rapid onset of inflammation caused by the infection of type 2 alveolar cells with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

2 Jul 2020

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

A new study published on the preprint server bioRxiv in June 2020 shows that a candidate spike protein vaccine can induce neutralizing antibodies, antiviral T cell responses, and protection against infection.

2 Jul 2020

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

2 Jul 2020

How lockdown stopped the virus in Italy

Previous studies have shown that many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases were tied to asymptomatic carriers or those who do not manifest symptoms of the viral infection. Now, a new study reveals that in the first Italian town hit by the virus, as much as 40 percent of the population had no symptoms of the coronavirus disease (COVID-19).

1 Jul 2020

Coronavirus immunity is higher than previously thought, study finds

Now, a team of researchers at the Karolinska Institutet and Karolinska University Hospital in Sweden has found that the number of people immune to COVID-10 may be higher than previously thought, and that antibody testing may no longer be the appropriate tool to trace it.

1 Jul 2020

Scientists find coronavirus' Achilles' heel

A team of scientists at the University of California San Francisco has found out how SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19) invades proteins in the cells that serve as master regulators of key cellular processes.

1 Jul 2020

Which facemasks work best at stopping coronavirus?

A new study shows how wearing masks can prevent the spread of droplet borne infections and is an excellent preventive measure to stop the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study titled, "Visualizing the effectiveness of face masks in obstructing respiratory jets," is published in the latest issue of the journal Physics of Fluids.

1 Jul 2020

New tool to increase accessibility for COVID-19 testing

A research group from the University of California Santa Barbara recently demonstrated a cost-effective, simple, and much less toxic method to isolate host and pathogen nucleic acids and proteins in order to streamline the detection of DNA and RNA viruses – including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

1 Jul 2020

New Yorkers grown more hesitant about resuming normal activities, survey shows

New Yorkers continue to report much higher than normal rates of depression and anxiety, but much less than at their peak in mid-April.

1 Jul 2020

UofM/UTHSC grant competition yields 23 projects addressing COVID-19

The University of Memphis and the University of Tennessee Health Science Center are teaming up in a venture to secure a portion of federal funding allocated for COVID-19 research.

1 Jul 2020